# Rocket Pharmaceuticals

Type: Company (RCKT)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/rocket-pharmaceuticals
Canonical HTML page: https://getfinancebrief.com/entity/rocket-pharmaceuticals

## Timeline

- **2026-03-19**: EU Complaint — Broadcom faces formal competition complaint from the EU regarding VMware.
- **2026-03-10**: SEC Filing — RCKT files notice of entry into/termination of material definitive agreements.
- **2026-02-27**: RCKT Earnings — Rocket Pharmaceuticals reports Q4 and Full Year 2025 financial results.

## Recent coverage (1 stories)

### Market Volatility Hits Rocket Pharmaceuticals and Broadcom Amid New Headwinds
2026-03-19 21:02:02 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Rocket Pharmaceuticals (RCKT) shares fell 4.4% following recent clinical and financial updates, while Broadcom (AVGO) slipped 1.1% as the company faces a new EU antitrust complaint regarding its VMware acquisition.
Full story: https://getfinancebrief.com/story/rocket-pharmaceuticals-broadcom-market-update-march-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.